Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 9;9(1):12900.
doi: 10.1038/s41598-019-49381-w.

Impact of Intermittent Hypoxia on Sepsis Outcomes in a Murine Model

Affiliations

Impact of Intermittent Hypoxia on Sepsis Outcomes in a Murine Model

Kun-Ta Chou et al. Sci Rep. .

Abstract

Sleep apnea has been associated with a variety of diseases, but its impact on sepsis outcome remains unclear. This study investigated the effect of intermittent hypoxia [IH]-the principal feature of sleep apnea-on murine sepsis. 5-week-old male C57BL6 mice were assigned to groups receiving severe IH (O2 fluctuating from room air to an O2 nadir of 5.7% with a cycle length of 90 seconds), mild IH (room air to 12%, 4 minutes/cycle), or room air for 3 weeks. Sepsis was induced by cecal ligation and puncture and survival was monitored. Sepsis severity was evaluated by murine sepsis scores, blood bacterial load, plasma tumor necrosis factor-α [TNF-α]/interleukin-6 [IL-6] levels and histopathology of vital organs. Compared with normoxic controls, mice subjected to severe IH had earlier mortality, a lower leukocyte count, higher blood bacterial load, higher plasma TNF-α and IL-6 levels, more severe inflammatory changes in the lung, spleen and small intestine. Mice subjected to mild IH did not differ from normoxic controls, except a higher IL-6 level after sepsis induced. The adverse impact of severe IH was reversed following a 10-day normoxic recovery. In conclusion, severe IH, not mild IH, contributed to poorer outcomes in a murine sepsis model.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The study design.
Figure 2
Figure 2
Profile of Intermittent hypoxia of the IH1 and IH2 protocols.
Figure 3
Figure 3
Levels of Inflammatory biomarkers and sepsis severity in mice. (A) leukocyte count, (B) TNF-α, (C) IL-6 (D)bacterial load, (E) sepsis scores. Post-CLP IH2 and control groups: n = 6; other groups: n = 5. *p < 0.05; #p < 0.05 for comparison between before and after CLP in each of the three groups (IH1/IH2/control).
Figure 4
Figure 4
Survival after cecal ligation and puncture. In comparison to normoxic controls, the IH1 group had significantly earlier mortality. The difference between IH1 and IH2 showed a trend toward statistical significance. p = 0.008 for three-group comparison. IH1 vs control: p = 0.002, IH1 vs IIH2: p = 0.056. n = 12 for each group.
Figure 5
Figure 5
Histopathologic evaluation with hematoxylin-eosin staining (magnification 40×). showed more prominent inflammatory changes in the lung, small intestine and spleen in the IH1 group than in the IH2 group and normoxic controls. Bar: 200 μm.
Figure 6
Figure 6
Histopathologic evaluation with hematoxylin-eosin staining (magnification 100×). The IH1 group had more severe inflammatory change than the IH group or normoxic controls. Scores of organ damage were shown on the last row. Bar: 100 μm.
Figure 7
Figure 7
Normoxic recovery. With a 10-day normoxic recovery following the IH1 protocol, sepsis severity (A) and mortality (B) did not differ significantly between the IH1 group and normoxic controls. n = 6 for each group.

Similar articles

Cited by

References

    1. Peppard PE, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177:1006–1014. doi: 10.1093/aje/kws342. - DOI - PMC - PubMed
    1. Floras JS. Sleep Apnea and Cardiovascular Disease: An Enigmatic Risk Factor. Circ Res. 2018;122:1741–1764. doi: 10.1161/CIRCRESAHA.118.310783. - DOI - PubMed
    1. Javaheri S, et al. Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. J Am Coll Cardiol. 2017;69:841–858. doi: 10.1016/j.jacc.2016.11.069. - DOI - PMC - PubMed
    1. Arnardottir ES, et al. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep. 2009;32:447–470. doi: 10.1093/sleep/32.4.447. - DOI - PMC - PubMed
    1. Martinez-Garcia MA, Chiner E. Sleep apnoea and risk of post-operative infection: beyond cardiovascular impact. Eur Respir J. 2017;49:1700292. doi: 10.1183/13993003.00292-2017. - DOI - PubMed

Publication types